J ANTIMICROB CHEMOTH 润色咨询

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

出版年份：1975 年文章数：7046 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：9.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=514888, encodeId=ca8a51488812, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Fri Aug 28 21:09:00 CST 2015, time=2015-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500482, encodeId=faf0500482eb, content=我在12月31号提交了一篇，当天就外审了，稿件号是1970, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jan 05 17:36:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500396, encodeId=f1f250039651, content=稿件，今年都超过2000了！！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 30 17:24:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499709, encodeId=ab13499e0995, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 07 10:39:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491281, encodeId=49074912813b, content=审稿超快，一天被拒。 <br> 高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 30 19:13:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472920, encodeId=bb1c4e29205b, content=2个月，据稿，确实很难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 11 12:02:00 CST 2010, time=2010-12-11, status=1, ipAttribution=)]
    2015-08-28 Fan of Vibrio

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=514888, encodeId=ca8a51488812, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Fri Aug 28 21:09:00 CST 2015, time=2015-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500482, encodeId=faf0500482eb, content=我在12月31号提交了一篇，当天就外审了，稿件号是1970, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jan 05 17:36:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500396, encodeId=f1f250039651, content=稿件，今年都超过2000了！！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 30 17:24:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499709, encodeId=ab13499e0995, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 07 10:39:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491281, encodeId=49074912813b, content=审稿超快，一天被拒。 <br> 高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 30 19:13:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472920, encodeId=bb1c4e29205b, content=2个月，据稿，确实很难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 11 12:02:00 CST 2010, time=2010-12-11, status=1, ipAttribution=)]
    2014-01-05 匿名用户

    我在12月31号提交了一篇，当天就外审了，稿件号是1970

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=514888, encodeId=ca8a51488812, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Fri Aug 28 21:09:00 CST 2015, time=2015-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500482, encodeId=faf0500482eb, content=我在12月31号提交了一篇，当天就外审了，稿件号是1970, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jan 05 17:36:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500396, encodeId=f1f250039651, content=稿件，今年都超过2000了！！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 30 17:24:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499709, encodeId=ab13499e0995, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 07 10:39:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491281, encodeId=49074912813b, content=审稿超快，一天被拒。 <br> 高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 30 19:13:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472920, encodeId=bb1c4e29205b, content=2个月，据稿，确实很难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 11 12:02:00 CST 2010, time=2010-12-11, status=1, ipAttribution=)]
    2013-12-30 匿名用户

    稿件，今年都超过2000了！！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=514888, encodeId=ca8a51488812, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Fri Aug 28 21:09:00 CST 2015, time=2015-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500482, encodeId=faf0500482eb, content=我在12月31号提交了一篇，当天就外审了，稿件号是1970, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jan 05 17:36:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500396, encodeId=f1f250039651, content=稿件，今年都超过2000了！！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 30 17:24:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499709, encodeId=ab13499e0995, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 07 10:39:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491281, encodeId=49074912813b, content=审稿超快，一天被拒。 <br> 高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 30 19:13:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472920, encodeId=bb1c4e29205b, content=2个月，据稿，确实很难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 11 12:02:00 CST 2010, time=2010-12-11, status=1, ipAttribution=)]
    2013-11-07 匿名用户

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=514888, encodeId=ca8a51488812, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Fri Aug 28 21:09:00 CST 2015, time=2015-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500482, encodeId=faf0500482eb, content=我在12月31号提交了一篇，当天就外审了，稿件号是1970, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jan 05 17:36:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500396, encodeId=f1f250039651, content=稿件，今年都超过2000了！！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 30 17:24:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499709, encodeId=ab13499e0995, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 07 10:39:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491281, encodeId=49074912813b, content=审稿超快，一天被拒。 <br> 高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 30 19:13:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472920, encodeId=bb1c4e29205b, content=2个月，据稿，确实很难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 11 12:02:00 CST 2010, time=2010-12-11, status=1, ipAttribution=)]
    2012-10-30 匿名用户

    审稿超快，一天被拒。
    高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=514888, encodeId=ca8a51488812, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：生科院做微生物的极少投这种耐药的杂志，反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR，交给公司测测序，没什么技术含量的低端套路。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Fri Aug 28 21:09:00 CST 2015, time=2015-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500482, encodeId=faf0500482eb, content=我在12月31号提交了一篇，当天就外审了，稿件号是1970, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jan 05 17:36:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500396, encodeId=f1f250039651, content=稿件，今年都超过2000了！！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 30 17:24:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499709, encodeId=ab13499e0995, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：与楼下这位同感，我也是被这个家伙拒掉的，基本没有正当理由，说我实验设计很awkward.我就操他妈了，AAC的审稿人都说innovative,interesting，我就真不知道这个杂志的高级编辑怎么这么牛逼？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 07 10:39:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491281, encodeId=49074912813b, content=审稿超快，一天被拒。 <br> 高级编辑（一德国歇顶）简直就是畜生，大概扫一眼就拒，连送审都没有，提出的comments让人哭笑不得。投AAC也有很积极的评价，不知道这个杂志今年怎么就这么牛。一句话，这个杂志不太适合中国人投，不信大家可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 30 19:13:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472920, encodeId=bb1c4e29205b, content=2个月，据稿，确实很难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 11 12:02:00 CST 2010, time=2010-12-11, status=1, ipAttribution=)]
    2010-12-11 匿名用户

    2个月，据稿，确实很难啊

    0

共42条页码: 3/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分